In the presence of tumor antigen, IL-12-loaded human serum albumin (HSA) nanoparticles are released from INS-CAR T, allowing for local and controlled IL-12 release (and recruitment of other CAR-T cells) (72). The gene discussed is ALB; the disease is neoplasm.